Live from the NIH registry
Studies recruiting near Ogden right now
Top 25 of 116 recruiting studies, sorted by proximity — each links to its official registry page
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
McKay-Dee Hospital Center — Ogden, Utah (0.4 mi)
· Sponsor: SWOG Cancer Research Network
Adaptation and Pilot Implementation of ePNa Clinical Decision Support for Utah Urgent Care Clinics
Pneumonia
N/A
Interventional 4,000 participants sought
South Ogden Instacare — South Ogden, Utah (2.5 mi)
· Sponsor: Intermountain Health Care, Inc.
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
Advanced Research Institute — Ogden, Utah (0.4 mi)
· Sponsor: TriGemX Bio, Inc.
Combination Antibiotic Therapy for Staphylococcus Aureus Bacteremia
Staphylococcus Aureus Bacteremia
Phase 4
Interventional 2,096 participants sought
McKay-Dee Hospital — Ogden, Utah (0.4 mi)
· Sponsor: Intermountain Health Care, Inc.
A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV)
Human Papilloma Virus (HPV), High-risk Human Papillomavirus Infection
Phase 2
Interventional 118 participants sought
Alpine Research Organization, Inc. — Layton, Utah (11.6 mi)
· Sponsor: Daré Bioscience, Inc.
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Phase 3
Interventional 1,295 participants sought
Farmington Health Center — Farmington, Utah (17.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
Migraine
Phase 4
Interventional 1,335 participants sought
Advanced Research Institute Ogden — Ogden, Utah (0.4 mi)
· Sponsor: Mayo Clinic
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Ogden, Utah (0.4 mi)
· Sponsor: Hoffmann-La Roche
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Ogden, Utah (0.4 mi)
· Sponsor: TG Therapeutics, Inc.
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Care Access - Ogden — Ogden, Utah (0.4 mi)
· Sponsor: Eli Lilly and Company
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
McKay-Dee Hospital Center — Ogden, Utah (0.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 3
Interventional 150 participants sought
Advanced Research Institute - Ogden — Ogden, Utah (0.4 mi)
· Sponsor: vTv Therapeutics
Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
Immune Thrombocytopenia
Phase 3
Interventional 60 participants sought
Community Cancer Trials of Utah-Investigational Site Number: 8400002 — Ogden, Utah (0.4 mi)
· Sponsor: Sanofi
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Type 2 Diabetes Mellitus, Type 2 Diabetes With Chronic Kidney Disease
Phase 3
Interventional 900 participants sought
Research Site — Ogden, Utah (0.4 mi)
· Sponsor: AstraZeneca
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
Diffuse Large B-cell Lymphoma (DLBCL)
Phase 3
Interventional 904 participants sought
Community Cancer Trials of Utah — Ogden, Utah (0.4 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study on the Safety of an Investigational Chickenpox Vaccine, When Given to Healthy Children, 12 to 15 Months of Age
Chickenpox
Phase 3
Interventional 750 participants sought
GSK Investigational Site — Roy, Utah (5.5 mi)
· Sponsor: GlaxoSmithKline
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,500 participants sought
McKay-Dee Hospital Center — Ogden, Utah (0.4 mi)
· Sponsor: NRG Oncology
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD (Chronic Obstructive Pulmonary Disease)
Phase 3
Interventional 5,250 participants sought
Research Site — Ogden, Utah (0.4 mi)
· Sponsor: AstraZeneca
Study of DONQ52 in Active Celiac Disease
Celiac Disease
Phase 2
Interventional 92 participants sought
Care Access Research - Ogden — Ogden, Utah (0.4 mi)
· Sponsor: Chugai Pharmaceutical
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 1,524 participants sought
Farmington Health Center — Farmington, Utah (17.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age
Pneumococcal Immunization, Healthy Volunteers
Phase 3
Interventional 2,195 participants sought
Rio Clinical Trials - Canyon View- Site Number : 8400031 — Ogden, Utah (0.4 mi)
· Sponsor: Sanofi
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma
Phase 3
Interventional 382 participants sought
Farmington Health Center — Farmington, Utah (17.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors
Advanced Solid Tumors
Phase 1
Interventional 220 participants sought
START Mountain — Ogden, Utah (0.4 mi)
· Sponsor: Vividion Therapeutics, Inc.
A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
Ulcerative Colitis
Phase 2
Interventional 99 participants sought
Investigational Site Number: 8400007 — Ogden, Utah (0.4 mi)
· Sponsor: Sanofi
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Colon Adenocarcinoma, Rectal Adenocarcinoma
Phase 3
Interventional 477 participants sought
Community Cancer Trials of Utah ( Site 0086) — Ogden, Utah (0.4 mi)
· Sponsor: Merck Sharp & Dohme LLC